Teneligliptin & Metformin Hydrochloride SR Tablets – Glytin M Tablets

Glytin M Tablets – Effective Combination for Consistent Diabetes Control.

Glytin M Tablets – The Dual Combination of teneligliptin & metformin hydrochloride sr tablets is used to is used to treat type 2 diabetes mellitus and type-2 diabetes mellitus is also known as non-insulin-dependent diabetes
The dual combination of medicines in Teneligliptin and Metformin hydrochloride. Teneligliptin works by stopping the action of the dipeptidyl peptidase-4 enzyme, which in turn increases the insulin levels in the body and reduces the glucagon levels. Metformin hydrochloride acts by decreasing liver glucose production and intestinal glucose uptake.

KEY BENEFITS of Teneligliptin & Metformin Hydrochloride SR Tablets – Glytin M Tablets
✅Dual Action for Optimal Blood Sugar Control: Teneligliptin enhances insulin secretion and reduces glucagon, while Metformin improves insulin sensitivity and reduces glucose production in the liver. This dual approach ensures better overall blood sugar control.
✅Long-Acting Formulation: The extended-release (SR) formulation of Metformin ensures consistent, sustained release of the medication, maintaining stable blood sugar levels while Teneligliptin provides quick and effective glucose-lowering action, making it ideal for long-term diabetes management.
✅Convenient Once-Daily Dosage: The once-daily dosage, providing convenience and improving patient adherence to the treatment regimen, especially for those with busy lifestyles or difficulty remembering multiple doses.

Recommended By Specialists:
👨‍⚕️Endocrinologists: To specialize in the management of metabolic disorders like diabetes, often recommend this combination therapy for type 2 diabetes. It offers effective blood sugar control by combining the insulin-enhancing action of Teneligliptin with the insulin-sensitizing properties of Metformin.
👨‍⚕️Diabetologists: A subset of endocrinologists, are specialists who focus solely on diabetes care as it dual therapy to improve glycemic control enough.
👨‍⚕️Primary Care Physicians (PCPs): For the patients with type 2 patients changes to manage their blood sugar levels and has common first line common.

INDICATIONS:
✅Type 2 Diabetes Mellitus
✅Long-Term Glycemic Control
✅Combination Therapy
✅Patients at Risk of Hypoglycemia